Literature DB >> 26872951

Comparative analysis of 3D culture methods on human HepG2 cells.

Claudia Luckert1,2, Christina Schulz1, Nadja Lehmann1, Maria Thomas3,4, Ute Hofmann3,4, Seddik Hammad5,6, Jan G Hengstler5, Albert Braeuning1, Alfonso Lampen1, Stefanie Hessel7.   

Abstract

Human primary hepatocytes represent a gold standard in in vitro liver research. Due to their low availability and high costs alternative liver cell models with comparable morphological and biochemical characteristics have come into focus. The human hepatocarcinoma cell line HepG2 is often used as a liver model for toxicity studies. However, under two-dimensional (2D) cultivation conditions the expression of xenobiotic-metabolizing enzymes and typical liver markers such as albumin is very low. Cultivation for 21 days in a three-dimensional (3D) Matrigel culture system has been reported to strongly increase the metabolic competence of HepG2 cells. In our present study we further compared HepG2 cell cultivation in three different 3D systems: collagen, Matrigel and Alvetex culture. Cell morphology, albumin secretion, cytochrome P450 monooxygenase enzyme activities, as well as gene expression of xenobiotic-metabolizing and liver-specific enzymes were analyzed after 3, 7, 14, and 21 days of cultivation. Our results show that the previously reported increase of metabolic competence of HepG2 cells is not primarily the result of 3D culture but a consequence of the duration of cultivation. HepG2 cells grown for 21 days in 2D monolayer exhibit comparable biochemical characteristics, CYP activities and gene expression patterns as all 3D culture systems used in our study. However, CYP activities did not reach the level of HepaRG cells. In conclusion, the increase of metabolic competence of the hepatocarcinoma cell line HepG2 is not due to 3D cultivation but rather a result of prolonged cultivation time.

Entities:  

Keywords:  3D cultivation; Cytochrome P450; HepG2 cells; Liver cell model; Xenobiotic metabolism

Mesh:

Substances:

Year:  2016        PMID: 26872951     DOI: 10.1007/s00204-016-1677-z

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  23 in total

1.  Impact of iron oxide nanoparticles on xenobiotic metabolism in HepaRG cells.

Authors:  Linn Voss; Kiymet Yilmaz; Lea Burkard; Janja Vidmar; Valerie Stock; Ute Hoffmann; Oliver Pötz; Helen Sophie Hammer; Matthias Peiser; Albert Braeuning; Katrin Löschner; Linda Böhmert; Holger Sieg
Journal:  Arch Toxicol       Date:  2020-09-10       Impact factor: 5.153

2.  Protein expression and function of organic anion transporters in short-term and long-term cultures of Huh7 human hepatoma cells.

Authors:  Melina M Malinen; Katsuaki Ito; Hee Eun Kang; Paavo Honkakoski; Kim L R Brouwer
Journal:  Eur J Pharm Sci       Date:  2019-01-24       Impact factor: 4.384

Review 3.  Microfluidics-based 3D cell culture models: Utility in novel drug discovery and delivery research.

Authors:  Nilesh Gupta; Jeffrey R Liu; Brijeshkumar Patel; Deepak E Solomon; Bhuvaneshwar Vaidya; Vivek Gupta
Journal:  Bioeng Transl Med       Date:  2016-07-05

4.  Development of 3D Hepatic Constructs Within Polysaccharide-Based Scaffolds with Tunable Properties.

Authors:  Marie-Noëlle Labour; Camile Le Guilcher; Rachida Aid-Launais; Nour El Samad; Soraya Lanouar; Teresa Simon-Yarza; Didier Letourneur
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

Review 5.  Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury.

Authors:  Yitian Zhou; Joanne X Shen; Volker M Lauschke
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

6.  Distribution of SiO2 nanoparticles in 3D liver microtissues.

Authors:  Jana Fleddermann; Julia Susewind; Henrike Peuschel; Marcus Koch; Isabella Tavernaro; Annette Kraegeloh
Journal:  Int J Nanomedicine       Date:  2019-02-22

7.  In vitro metabolic activation of vitamin D3 by using a multi-compartment microfluidic liver-kidney organ on chip platform.

Authors:  Jannick Theobald; Mohamed A Abu El Maaty; Nico Kusterer; Bernhard Wetterauer; Michael Wink; Xinlai Cheng; Stefan Wölfl
Journal:  Sci Rep       Date:  2019-03-15       Impact factor: 4.379

8.  Establishing a 3D In Vitro Hepatic Model Mimicking Physiologically Relevant to In Vivo State.

Authors:  Hyun Kyoung Kang; Madina Sarsenova; Da-Hyun Kim; Min Soo Kim; Jin Young Lee; Eun-Ah Sung; Myung Geun Kook; Nam Gyo Kim; Soon Won Choi; Vyacheslav Ogay; Kyung-Sun Kang
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

9.  Bilirubin detoxification using different phytomaterials: characterization and in vitro studies.

Authors:  Betty Titus Mathew; Shaima Raji; Sawsan Dagher; Ali Hilal-Alnaqbi; Abdel-Hamid Ismail Mourad; Sulaiman Al-Zuhair; Mahmoud Al Ahmad; Khaled Abbas El-Tarabily; Amr Amin
Journal:  Int J Nanomedicine       Date:  2018-05-23

Review 10.  Comparison of conventional and advanced in vitro models in the toxicity testing of nanoparticles.

Authors:  Eleonore Fröhlich
Journal:  Artif Cells Nanomed Biotechnol       Date:  2018-06-29       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.